KKH Kaufmännische Krankenkasse
Germany · 709 open tenders · 486 documented awards
Current tenders
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the named active substances with the possibility of conclusion within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the mentioned active substances with the option of conclusion within the scope of the so-called Open-House procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the aforementioned active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the specified active substances with the option to conclude agreements within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the aforementioned active ingredients with the option to conclude within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the aforementioned active substances with the possibility of conclusion within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the specified active substances with the option to conclude agreements within the scope of the so-called Open-House procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the named active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive rebate agreements pursuant to § 130a Para. 8 SGB V for the stated active substances with conclusion option within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the stated active ingredients with the option of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the active ingredients mentioned, with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the stated active substances with concluding option within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the stated active substances with the possibility of conclusion within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the named active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the named active substances with conclusion option within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the active ingredients mentioned with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Medicines – Conclusion of non-exclusive rebate agreements pursuant to § 130a (8) SGB V for the mentioned active substances with conclusion option within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the active ingredients mentioned, with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the specified active substances with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the specified active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the aforementioned active substances with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the mentioned active substances with conclusion option within the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the named active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the specified active ingredients with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the active substances mentioned with the option to conclude within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the active ingredients mentioned with the possibility of concluding an agreement within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Germany – Pharmaceuticals – Conclusion of non-exclusive rebate agreements pursuant to § 130a para. 8 SGB V for the stated active ingredients with conclusion possibility within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a (8) SGB V for the named active substances with the possibility of conclusion within the scope of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 SGB V for the active substances mentioned with the possibility of conclusion within the framework of the so-called open-house procedure.
Deadline 31 Dec · 133 days left
Purchasing rhythm
Awards per year — who knows the rhythm prepares before the notice appears.
2018108
201991
202050
202147
2022134
2023230
2024229
2025375
2026115
Who has won here before
| Company | Awards | Period |
|---|---|---|
| mibe GmbH Arzneimittel · Sandersdorf-Brehna | 8 | 2013–2016 |
| betapharm Arzneimittel GmbH · Augsburg | 8 | 2013–2016 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 8 | 2013–2016 |
| Basics GmbH · Leverkusen | 8 | 2013–2016 |
| Aliud Pharma GmbH · Laichingen | 8 | 2013–2016 |
| Hexal AG · Holzkirchen | 7 | 2013–2016 |
| TAD Pharma GmbH · Cuxhaven | 7 | 2013–2016 |
| 1 A Pharma GmbH · Oberhaching | 7 | 2013–2016 |
| Bluefish Pharma GmbH · Griesheim | 7 | 2013–2016 |
| SANIMED GmbH · Ibbenbüren | 7 | 2012–2018 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.